Rakovina Therapeutics Inc (RKV) — Net Asset Quality Index
Rakovina Therapeutics Inc (RKV) has a Net Asset Quality Index of 35.8% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CA$5.27 Million minus total liabilities of CA$3.38 Million yields net assets of CA$1.89 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Rakovina Therapeutics Inc for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Rakovina Therapeutics Inc Net Asset Quality Index Over Time (2021–2024)
This chart shows how Rakovina Therapeutics Inc's Net Asset Quality Index has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the index stands at 35.8%, representing net assets of CA$1.89 Million against total assets of CA$5.27 Million CAD. For live market cap and overall valuation, see Rakovina Therapeutics Inc (RKV) total market value.
Annual Net Asset Quality Index for Rakovina Therapeutics Inc (2021–2024)
The table below presents the year-by-year Net Asset Quality Index for Rakovina Therapeutics Inc from 2021 to 2024, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See Rakovina Therapeutics Inc (RKV) shareholders funds for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (CAD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 68.9% | CA$4.30 Million | CA$6.24 Million | CA$1.94 Million | ▼ -2.2 pp |
| 2023 | 71.1% | CA$3.66 Million | CA$5.15 Million | CA$1.49 Million | ▼ -27.2 pp |
| 2022 | 98.3% | CA$6.01 Million | CA$6.12 Million | CA$107.05K | ▼ -0.4 pp |
| 2021 | 98.7% | CA$8.54 Million | CA$8.66 Million | CA$113.98K | — |